575 related articles for article (PubMed ID: 31541333)
1. Diabetic macular edema with neuroretinal detachment: OCT and OCT-angiography biomarkers of treatment response to anti-VEGF and steroids.
Vujosevic S; Toma C; Villani E; Muraca A; Torti E; Florimbi G; Leporati F; Brambilla M; Nucci P; De Cilla' S
Acta Diabetol; 2020 Mar; 57(3):287-296. PubMed ID: 31541333
[TBL] [Abstract][Full Text] [Related]
2. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.
Vujosevic S; Torresin T; Bini S; Convento E; Pilotto E; Parrozzani R; Midena E
Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223
[TBL] [Abstract][Full Text] [Related]
3. Optical Coherence Tomography Angiography of DME and Its Association with Anti-VEGF Treatment Response.
Lee J; Moon BG; Cho AR; Yoon YH
Ophthalmology; 2016 Nov; 123(11):2368-2375. PubMed ID: 27613201
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers.
Bonfiglio V; Reibaldi M; Pizzo A; Russo A; Macchi I; Faro G; Avitabile T; Longo A
Acta Ophthalmol; 2019 Jun; 97(4):e540-e544. PubMed ID: 30318792
[TBL] [Abstract][Full Text] [Related]
5. Subthreshold Micropulse Laser in Diabetic Macular Edema: 1-Year Improvement in OCT/OCT-Angiography Biomarkers.
Vujosevic S; Toma C; Villani E; Brambilla M; Torti E; Leporati F; Muraca A; Nucci P; De Cilla S
Transl Vis Sci Technol; 2020 Sep; 9(10):31. PubMed ID: 33062394
[TBL] [Abstract][Full Text] [Related]
6. Optical coherence tomography biomarkers DROL, PROS, SND, hyperreflective walls of foveal cystoid spaces as predictors of central macular thickness and visual acuity in diabetic macular edema treated with intravitreal ranibizumab.
Sardana A; Singh K; Singh A; Singh VK
Indian J Ophthalmol; 2024 May; 72(5):722-727. PubMed ID: 38648434
[TBL] [Abstract][Full Text] [Related]
7. OCT Angiography Biomarkers for Predicting Visual Outcomes after Ranibizumab Treatment for Diabetic Macular Edema.
Hsieh YT; Alam MN; Le D; Hsiao CC; Yang CH; Chao DL; Yao X
Ophthalmol Retina; 2019 Oct; 3(10):826-834. PubMed ID: 31227330
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of optical coherence tomography after switch to dexamethasone in diabetic macular edema.
Cavalleri M; Cicinelli MV; Parravano M; Varano M; De Geronimo D; Sacconi R; Bandello F; Querques G
Acta Diabetol; 2020 Feb; 57(2):163-171. PubMed ID: 31375899
[TBL] [Abstract][Full Text] [Related]
9. Optical Coherence Tomography (Angiography) Biomarkers in the Assessment and Monitoring of Diabetic Macular Edema.
Suciu CI; Suciu VI; Nicoara SD
J Diabetes Res; 2020; 2020():6655021. PubMed ID: 33490283
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effect of ranibizumab and dexamethasone implant on serous retinal detachment in diabetic macular edema.
Demircan A; Ozkaya A; Alkin Z; Kemer B; Yesilkaya C; Demir G
J Fr Ophtalmol; 2018 Oct; 41(8):733-738. PubMed ID: 30213609
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment.
Kaya M; Karahan E; Ozturk T; Kocak N; Kaynak S
Korean J Ophthalmol; 2018 Aug; 32(4):296-302. PubMed ID: 30091308
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of retinal inflammatory biomarkers after intravitreal steroid implant and Ranibizumab injection in diabetic macular edema.
Muftuoglu IK; Tokuc EO; Sümer F; Karabas VL
Eur J Ophthalmol; 2022 May; 32(3):1627-1635. PubMed ID: 34219488
[TBL] [Abstract][Full Text] [Related]
13. MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.
Santos AR; Alves D; Santos T; Figueira J; Silva R; Cunha-Vaz JG
Retina; 2019 Jan; 39(1):52-60. PubMed ID: 29077605
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal Ranibizumab and Dexamethasone Implant Injections as Primary Treatment of Diabetic Macular Edema: The Month 24 Results from Simultaneously Double Protocol.
Kaya M; Atas F; Kocak N; Ozturk T; Ayhan Z; Kaynak S
Curr Eye Res; 2023 May; 48(5):498-505. PubMed ID: 36629472
[TBL] [Abstract][Full Text] [Related]
15. Predicting visual outcomes following anti-vascular endothelial growth factor treatment for diabetic macular edema.
Rana V; Agarwal A; Arora A; Bansal R; Dogra M; Bhadada SK; Singh N; Gupta V
Indian J Ophthalmol; 2024 Jan; 72(Suppl 1):S16-S21. PubMed ID: 38131536
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Analysis of Retinal Microvascular Perfusion and Novel Biomarkers of the Treatment Response in Diabetic Macular Edema.
Park YG; Park YH
J Diabetes Res; 2020; 2020():2132037. PubMed ID: 33282960
[TBL] [Abstract][Full Text] [Related]
17. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CHANGES AFTER SUBTHRESHOLD MICROPULSE YELLOW LASER IN DIABETIC MACULAR EDEMA.
Vujosevic S; Gatti V; Muraca A; Brambilla M; Villani E; Nucci P; Rossetti L; De Cilla' S
Retina; 2020 Feb; 40(2):312-321. PubMed ID: 31972802
[TBL] [Abstract][Full Text] [Related]
18. Subthreshold Photocoagulation, Laser Endpoint Management Based on Optical Coherence Tomography Angiography in Cases of Diabetic Macular Edema Refractory to Anti-VEGF.
Karasu B; Akbas YB; Aykut A; Çelebi ARC
Klin Monbl Augenheilkd; 2024 Feb; 241(2):197-208. PubMed ID: 35453154
[TBL] [Abstract][Full Text] [Related]
19. Diabetic Macular Edema With and Without Subfoveal Neuroretinal Detachment: Two Different Morphologic and Functional Entities.
Vujosevic S; Torresin T; Berton M; Bini S; Convento E; Midena E
Am J Ophthalmol; 2017 Sep; 181():149-155. PubMed ID: 28687219
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of macular morphology and microcirculation in diabetic macular edema patients with serous retinal detachment.
Xu M; Xu H; Li X; Chen F
BMC Ophthalmol; 2022 Jul; 22(1):299. PubMed ID: 35820875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
